IRIS Accounts Production v25.4.0.155 04514179 Board of Directors 31.3.24 30.3.25 30.3.25 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh045141792024-03-30045141792025-03-30045141792024-03-312025-03-30045141792023-03-30045141792023-03-312024-03-30045141792024-03-3004514179ns15:EnglandWales2024-03-312025-03-3004514179ns14:PoundSterling2024-03-312025-03-3004514179ns10:Director12024-03-312025-03-3004514179ns10:PrivateLimitedCompanyLtd2024-03-312025-03-3004514179ns10:SmallEntities2024-03-312025-03-3004514179ns10:AuditExempt-NoAccountantsReport2024-03-312025-03-3004514179ns10:SmallCompaniesRegimeForDirectorsReport2024-03-312025-03-3004514179ns10:SmallCompaniesRegimeForAccounts2024-03-312025-03-3004514179ns10:FullAccounts2024-03-312025-03-3004514179ns5:CurrentFinancialInstruments2025-03-3004514179ns5:CurrentFinancialInstruments2024-03-3004514179ns5:Non-currentFinancialInstruments2025-03-3004514179ns5:Non-currentFinancialInstruments2024-03-3004514179ns5:ShareCapital2025-03-3004514179ns5:ShareCapital2024-03-3004514179ns5:RetainedEarningsAccumulatedLosses2025-03-3004514179ns5:RetainedEarningsAccumulatedLosses2024-03-3004514179ns10:RegisteredOffice2024-03-312025-03-3004514179ns5:LeaseholdImprovements2024-03-312025-03-3004514179ns5:FurnitureFittings2024-03-312025-03-3004514179ns5:ComputerEquipment2024-03-312025-03-3004514179ns5:LeaseholdImprovements2024-03-3004514179ns5:FurnitureFittings2024-03-3004514179ns5:ComputerEquipment2024-03-3004514179ns5:LeaseholdImprovements2025-03-3004514179ns5:FurnitureFittings2025-03-3004514179ns5:ComputerEquipment2025-03-3004514179ns5:LeaseholdImprovements2024-03-3004514179ns5:FurnitureFittings2024-03-3004514179ns5:ComputerEquipment2024-03-3004514179ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3004514179ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3004514179ns5:Secured2025-03-3004514179ns5:Secured2024-03-30
REGISTERED NUMBER: 04514179 (England and Wales)














Unaudited Financial Statements

for the Year Ended 30 March 2025

for

Bioventures Consulting Ltd

Bioventures Consulting Ltd (Registered number: 04514179)






Contents of the Financial Statements
for the Year Ended 30 March 2025




Page

Balance Sheet 1

Notes to the Financial Statements 2


Bioventures Consulting Ltd (Registered number: 04514179)

Balance Sheet
30 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 33,712 34,054
Investment property 5 1,121,542 1,121,542
1,155,254 1,155,596

CURRENT ASSETS
Debtors 6 24,623 52,984
Cash at bank 46,612 74,391
71,235 127,375
CREDITORS
Amounts falling due within one year 7 36,327 44,395
NET CURRENT ASSETS 34,908 82,980
TOTAL ASSETS LESS CURRENT LIABILITIES 1,190,162 1,238,576

CREDITORS
Amounts falling due after more than one year 8 (768,928 ) (765,960 )

PROVISIONS FOR LIABILITIES (181 ) (203 )
NET ASSETS 421,053 472,413

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 420,953 472,313
SHAREHOLDERS' FUNDS 421,053 472,413

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 December 2025 and were signed on its behalf by:




Dr S J Rees - Director


Bioventures Consulting Ltd (Registered number: 04514179)

Notes to the Financial Statements
for the Year Ended 30 March 2025

1. STATUTORY INFORMATION

Bioventures Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 04514179

Registered office: Ebenezer House
Ryecroft
Newcastle under Lyme
Staffordshire
ST5 2BE

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue is recognised as the company becomes entitled to consideration for the services supplied. Therefore, turnover also includes the element of work completed but not yet invoiced.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - NIL % per annum
Fixtures and fittings - 15% on reducing balance
Computer equipment - 33% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Bioventures Consulting Ltd (Registered number: 04514179)

Notes to the Financial Statements - continued
for the Year Ended 30 March 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 31 March 2024
and 30 March 2025 32,986 455 9,239 42,680
DEPRECIATION
At 31 March 2024 - 400 8,226 8,626
Charge for year - 8 334 342
At 30 March 2025 - 408 8,560 8,968
NET BOOK VALUE
At 30 March 2025 32,986 47 679 33,712
At 30 March 2024 32,986 55 1,013 34,054

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 31 March 2024
and 30 March 2025 1,121,542
NET BOOK VALUE
At 30 March 2025 1,121,542
At 30 March 2024 1,121,542

The director considers the property to be shown at fair value.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 18,801 47,120
Other debtors 5,822 5,864
24,623 52,984

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Taxation and social security 32,276 40,343
Other creditors 4,051 4,052
36,327 44,395

Bioventures Consulting Ltd (Registered number: 04514179)

Notes to the Financial Statements - continued
for the Year Ended 30 March 2025

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans 519,182 561,336
Other creditors 249,746 204,624
768,928 765,960

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 519,182 561,336

9. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£    £   
Bank loans 519,182 561,336

The mortgages are secured by a charge on the residential properties at 118 Sweets Way, London, 8 Oxford Gardens, Stafford, 42 Newall Street,Cannock,74 Stafford Street, Cannock.